We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Ultracompact Microscope Enables High-Performance Imaging for Biomedical Diagnosis

By LabMedica International staff writers
Posted on 01 Aug 2022
Print article
Image: A chip-scale metalens array makes this microscope system ultracompact (Photo courtesy of Nanjing University)
Image: A chip-scale metalens array makes this microscope system ultracompact (Photo courtesy of Nanjing University)

Metalens technology opens a new way to achieve ultracompact and lightweight optical imaging systems. A metalens is a kind of metasurface composed of subwavelength units with powerful capability for manipulating light. An innovative polarization multiplexed metalens array (based on silicon nanoposts) was proposed to realize a compact and wide-field microscope that breaks conventional field-of-view (FOV) constraints, but the imaging quality is relatively poor due to its low efficiency with background noise, and the overall FOV is still smaller than that of traditional microscope with the same resolution. Significantly improved imaging quality is now possible with higher-resolution imaging, thanks to researchers who developed a polarizer-embedded metalens imaging device (PMID).

The PMID developed by researchers from Nanjing University (Jiangsu, China) is implemented based on a silicon nitride metasurface mounted on a CMOS image sensor with a fixed circular-polarization filter inserted between the two. It eliminates background noises, and even enables zoom-in imaging. The new system is based on a special co-and-cross-multiplexed metalens array and embedded polarizer. By integrating them to a chip-scale CMOS sensor, the researchers successfully developed a high-quality wide FOV and large depth-of-field (DOF) microscopy technique.

Significantly high performances are achieved, with a 4×4-mm2 FOV, a 1.74-μm resolution (limited by the CMOS pixel size), and a ~200-μm DOF (450-510-nm wavelength range). This FOV is around 5 to 7 times that of a traditional microscope with the same resolution. The team demonstrated the outstanding microscopy performance by imaging a large number of bio-specimens. This chip-scale microscope promises to revolutionize traditional optical devices, presenting a new horizon of ultracompact imaging devices powered by metatechnology.

“To the best of our knowledge, this is the first time a metalens imager has accessed a larger FOV than a traditional microscope with similar imaging quality,” said Tao Li, senior author and principal investigator at Nanjing University’s National Laboratory of Solid-State Microstructures. “By sweeping the illumination wavelength, the device is able to achieve large depth-of-field imaging simultaneously, thanks to the large dispersive nature of the metalens. This chip-scale PMID enables the implementation of miniaturized portable microscope system, with a thousand-fold reduction in volume and weight compared to a traditional microscope.”

Related Links:
Nanjing University 

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.